Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.
A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.
A new, smart pacemaker is integrated into a coordinated network of four soft, flexible, wireless, wearable sensors and control units placed around the upper body.
A new Northwestern Medicine study has found almost half of U.S. adults with heart failure have poorly controlled hypertension and diabetes.
Northwestern Medicine scientists have uncovered a key regulator of pregnancy-associated heart growth, according to a recent study published in the Journal of Clinical Investigation.
Expanding prescription of statin medication to reduce low-density lipoprotein cholesterol could be a cost-effective intervention against cardiovascular disease, according to a recent study.
Expression of a growth factor after heart injury activates the lymphatic system, spurring leukocytes to help clear away dying cells, according to a recent study.
A recent study published in Nature Genetics identified 10 new genetic regions associated with Brugada syndrome, a cardiac arrhythmia disorder.
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.